Autocrine embryotropins act as survival signals for the preimplantation embryo. In this study we examined the role of Paf in the transcription of the key proto-oncogenes Bcl2 and Fos. Transcripts were detected in oocytes and some cohorts of zygotes but not in cohorts of 2-cell, 8-cell, and blastocyst stage embryos. Immunolocalization of BCL2 and FOS showed little staining in oocytes and zygotes but increased staining in the embryo from the 2-cell to blastocyst stage. Paf (37 nM) treatment of 2-cell embryos caused an alpha-amanitin (26 lM)-sensitive increase in Bcl2 and Fos transcripts 20 min after treatment that subsided by 40 min. This increase was blocked by inhibition of calcium (by BAPTA-AM) or phosphatidylinositol-3-kinase signaling (by LY294002). Paf challenge also caused increased staining of BCL2 and FOS. Increased staining of FOS required new protein synthesis that had a half-life of 2-4 h after Paf challenge. Only a small proportion (;12%) of individual 2-cell embryos collected from the reproductive tract had detectable Bcl2 and Fos. This dichotomous pattern of transcript expression is consistent with the known periodic actions of Paf (which has a periodicity of ;90 min) and the relatively short half-life of the resulting transcripts. A BCL2 antagonist (HA14-1) caused a dose-dependent decrease in the capacity of cultured zygotes to develop to morphological blastocysts, which was partially reversed by the simultaneous addition of Paf to medium. The results show that Paf induces periodic transient transcriptions of key proto-oncogenes that result in the persistent presence of the resulting proteins in the preimplantation phase of development.
INTRODUCTION
The development of the preimplantation embryo is characterized by a number of autonomous rounds of cell proliferation that result in the formation of the blastocyst. The production and release of a range of autocrine embryotropins have a role in maintaining survival of the embryo in the presence of this apparently constitutive mitotic drive. Survival signaling is commonly transduced by the 1-o-phosphatidylinositol-3-kinase (PI3-kinase) signaling pathway, and the activity of PI3-kinase is necessary for early mouse embryo development [1] . Autocrine embryotropins including 1-o-alkyl-2-acetyl-sn-glycero-3-phosphocholine (Paf; Sigma) [2, 3] , IGF1 [4] , and TGFA [5] all activate the PI3-kinase pathway in the preimplantation-stage embryo. It is likely that a range of embryotropins acts across the preimplantation stage to induce survival by PI3-kinase signaling [6] . The downstream targets of this survival signaling have yet to be fully characterized.
Paf was discovered first and is, to date, the bestcharacterized embryotropin [7] . Paf is produced and released by embryos soon after fertilization. The presence of albumin in the medium (in vitro) acts as an acceptor for the released Paf. This extracellular Paf then acts as a ligand to bind a membrane receptor, creating an autocrine tropic loop [8] . The embryo's response to receptor occupancy is transduced by the activation of PI3-kinase [3] . This causes the release of intracellular calcium stores and the influx of extracellular calcium [9] , resulting in a transient increase in the intracellular calcium concentration. This is accompanied by a transient increase in transmembrane potassium and chloride currents [10, 11] . Inhibition of these transient increases in intracellular calcium concentration or the chloride current block the normal survival and development of the mouse zygote in vitro [11, 12] .
The calcium transients induced by Paf occur in the early embryo with a periodicity of approximately 90-120 min. Between each of these transients, the embryo is refractory to further stimulation by Paf [12] . Calcium transients result in the calmodulin-dependent phosphorylation of CREB (at serine 133) [13] . Phosphorylation of CREB causes it to become an active transcription factor [14] . Paf-induced calcium transients lead to the accumulation of phosphorylated CREB in the nucleus of the 2-cell embryo at the time definitive transcription from the new embryonic genome occurs [13, 15] . CREB is capable of causing the production of a very diverse transcriptome in a variety of cell types [16] . The expression of CREB (and its heterodimeric binding partner, ATF1) is essential to the normal development and survival of the early embryo [17] , suggesting that activation of CREB-mediated transcription may form an important component of the survival signaling pathway induced by autocrine embryotropins.
The CREB family of transcription factors generates a diverse transcriptome capable of supporting cell survival in somatic cells, and this has been most fully investigated in neuronal signaling [18] . Examples of important CREB targets include the Bcl2 and Fos genes. Bcl2 is a proto-oncogene that has prosurvival roles. BCL2 acts at the mitochondrial membrane to maintain the sequestration of proapoptotic mediators (such as BAX) within that subcellular compartment. BCL2 can also dimerize with proapoptotic members of the BH domain family of proteins, mitigating their actions [19] . Fos is a proto-oncogene that is a member of the immediate-early response family of transcription factors. Its transcription is commonly activated in response to exogenous ligands. It acts (commonly in association with JUN) to regulate proliferation, differentiation, and cell survival in a context-specific manner [20] .
The activation of CREB by Paf at the time transcription from the embryonic genome is first activated at the 2-cell stage [15] offers the possibility that CREB forms part of the machinery that governs the formation of this first transcriptome. This hypothesis predicts that transcripts from the Bcl2 and Fos target genes would be enriched at this time. However, interrogation of gene expression in the early embryo failed to consistently detect Fos transcripts [21] , while Bcl2 expression is highly heterogeneous [22] . These findings are not obviously consistent with a role for Paf-induced CREBmediated transcription in the early embryo.
In this study we have reassessed Bcl2 and Fos transcription in the early embryo, with particular emphasis on the effects of tropic stimulation. We found that Paf induced the periodic, short-lived transcription of both Bcl2 and Fos. Such pulses of transcription were sufficient to maintain high levels of BCL2 and FOS in the preimplantation embryo. Pharmacological inhibition of BCL2 compromised embryo development and survival in a Paf-dependent manner. The study shows that autocrine embryotropins induce characteristic patterns of transcription of key proto-oncogenes in the early embryo.
MATERIALS AND METHODS

Animals
The use of animals was carried out in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes and was approved by the Institutional Animal Care and Ethics Committee. Hybrid (C57BL/6 3 CBA/He), C57BL/6 (B6), and Paf-receptor null (Ptafr À/À ) mice were used in experiments. All animals were kept under 12L:12D cycle conditions and had access to food and water ad libitum. Six-week-old females were superovulated by intraperitoneal injection of 5 IU of equine chorionic gonadotropin (Folligon; Intervet International, Boxmeer, The Netherlands), followed 48 h later by 5 IU of human chorionic gonadotropin (hCG; Chorulon, Intervet). Females were paired with males of proven fertility or were unpaired with males for collection of oocytes. Pregnancy was confirmed by the presence of a copulation plug the following morning (Day 1).
Mouse Embryo Collection and Culture
Cumulus masses were collected from the reproductive tract at 20-21 h posthCG injection in Hepes-buffered modified human tubal fluid medium. Oocytes or zygotes were freed from their cumulus cells by brief exposure to 300 IU of hyaluronidase (Sigma Chemical Co., St. Louis, MO) and cultured in modified human tubal fluid medium (modHTF) [23] . All components of the medium were tissue culture grade (Sigma) and contained 3 mg of bovine serum albumin/ ml, unless otherwise stated (Sigma). Embryos were cultured individually in 10-ll volumes in 60-well plates (LUX 5260; Nunc, Naperville, IL) overlaid with 
Pharmacological Agents and Treatments
Paf was prepared as previously described [24] . To assess the regulation of Bcl2 and Fos expression, hybrid 1-cell embryos were cultured individually in 10 ll of mHTF medium for 20 h. The resulting 2-cell embryos were recovered in minimal volume and assigned individually to treatments in 10 ll of medium. Treatments were i) control medium alone; ii) 37 nM Paf; iii) 26 lM a-amanitin; iv) 50 lM BAPTA-AM; and v) 10 lM LY294002. Inhibitors were applied either alone or in conjunction with Paf treatment. 
Real-Time Quantitative RT-PCR
Extraction of embryo RNA and real-time quantitative RT-PCR (qRT-PCR) were performed as described previously [25] . In brief, mouse oocytes and embryos were collected from the reproductive tracts and washed in cold PBS three times and transferred in minimal volume as a group of 30 into 10 ll of extraction buffer. RNA was extracted by three repeats of freezing in liquid nitrogen and thawing with vortexing. The RNA was purified with an RQ1 RNase-free DNase kit (Promega, Alexandria NSW, Australia) and was subjected to reverse transcription with 2.5 lM random decamers (Applied Biosystems/Ambion). For the study of gene expression in individual embryos, one embryo was transferred into 1 ll of extraction buffer, and RNA was extracted by three repeats of freezing in liquid nitrogen and thawing on ice. Reverse transcription was performed in a total volume of 4 ll, with 2.5 lM random decamers. Negative controls for all reactions were without reverse transcriptase or without the RNA sample (to test for any RNA or DNA contamination, respectively). An internal positive control was used to test for expression of the Actb housekeeper gene. Amplification of cDNA used the sequence-specific primers, as follows: Actb, 5 0 -CTAAGGCCAACCGT GAAAAG and 3 0 -GTACGACCAGAGGCATACAG (predicted transcript size, 109 bp); Bcl2, 5 0 -CCTGTGGATGACTGAGTACC and 3 0 -GAGACAGCC AGGAGAAAT (110 bp); and Fos, 5 0 -ATCGGCAGAAGGGGCAAAGTAG and 3 0 -CAACGCAGACTTCTCATCTTAAG (171 bp). Real-time qPCR analysis was performed with a Rotor Gene 3000 real-time thermal cycler (Corbett Life Science, Sydney, Australia). The PCR cycling conditions were 958C for 10 min and then 40 cycles of 958C for 15 sec, 608C for 30 sec, and 728C for 45 sec. The DC t (¼ C t [Bcl2 or Fos] À C t [Actb]) was a measure of relative changes in the Bcl2 or Fos mRNA content of the embryo (C t , cycle threshold). Data were normalized to the control treatments or tissue mRNA levels. The number of 2 À(normalized DCt) was plotted.
Immunofluorescence
Immunofluorescence was carried out as previously described [26] . After fixation and blocking, embryos were incubated overnight at 48C with primary antibodies: 4 lg/ml anti-BCL2 (N-19, sc-492, rabbit anti-BCL2 polyclonal immunoglobulin G [IgG]; Santa Cruz Biotechnology, Santa Cruz, CA); 4 lg/ml anti-FOS (Ab-2, rabbit anti-FOS polyclonal IgG; Merck), or an equivalent concentration of isotype control immunoglobulin (negative control). Primary antibodies diluted to 1:200 were detected by secondary antibodies coupled to fluorescein isothiocyanate (goat anti-rabbit FITC-conjugated IgG; Sigma) for 1 h at room temperature. Whole-section imaging was performed with mercury lamp ultraviolet illumination and epifluorescence. These images were subjected to deconvolution using Sharpstack software (Media Cybernetics, Inc. Silver Spring, MD). Quantitative analysis of antigen staining was performed using Image-Pro Plus software (version 6.3; Media Cybernetics).
For each experiment, embryos from each treatment were processed at the same time and in parallel. All treatments were exposed to the same preparations and dilutions of all reagents including primary and secondary antibodies. Similarly, all preparations from an experiment were examined microscopically during the same session, and identical microscope and camera settings were used. All image analyses were performed in an identical manner for all embryos within an experiment. All preparations were performed by the same experienced operator throughout the study.
Western Blot Analysis
Western blot analysis was performed as previously described [27] . Fresh hybrid blastocyst embryos were collected and washed three times in cold PBS and then transferred to extraction buffer containing Triton X-100 (Bio-Rad), 24 mM deoxycholic acid, 0.2% (w/v) sodium dodecyl sulfate (SDS), 20 mM NaF, 20 mM Na 4 P 2 O 7 , 2 mM phenylmethanesulphonylfluoride, 3.08 mM aprotinin, Paf-INDUCED TRANSCRIPTION OF ONCOGENES 1219 42 mM leupeptin, and 2.91 mM pepstatin A (all from Sigma) in PBS. Embryos were lysed by using three cycles of freezing in liquid nitrogen and thawing (with vortexing). Harvesting of MBL5 embryonic stem (ES) and F9 embryonic carcinoma (EC) cells and extraction of protein were described previously [15] . The samples were diluted with Laemmli loading buffer and separated on 20% homogenous SDS-polyacrylamide gels (Amersham Pharmacia Biotech) using a PhastSystem apparatus (PhastSystem separation and control unit; Pharmacia, Sweden). The proteins were transferred onto polyvinylidene fluoride transfer membrane (Hybond-P; Amersham) with transfer buffer containing 12 mM Tris (Sigma), 96 mM glycine (BDH, Sydney, Australia), and 20% (v/v) methanol (BDH) by using a semidry PhastTransfer system (Amersham Pharmacia Biotech). The membrane was incubated in 10 ml of blocking buffer containing 2.5% (w/v) skim milk powder (Diploma, New Zealand) and then stained with 0.4 lg/ml rabbit anti-BCL2 IgG or 0.4 lg/ml anti-FOS IgG in blocking buffer at 48C overnight on a shaker. Primary antibody was detected with a 1:5000 dilution of horseradish peroxidase-conjugated secondary antibody (Sigma) and detected using chemiluminescence. The membrane was incubated in Super Signal West Femto (Pierce, Rockford, IL) diluted 1:4. The molecular size of the bands was determined with Labworks version 4.5 software (UVP, Inc., Upland) by comparison with a Precision Plus protein standard (Bio-Rad).
Statistical Analysis
The statistical analysis was performed with SPSS software for Windows (version 17.0; SPSS Inc., Chicago, IL). The numbers of nuclei in each blastocyst and the normalized relative transcript numbers were analyzed by univariate analysis of variance. In the model, they were set as the dependent variables, and test compound concentrations and embryo strains were set as the independent variables. The replicates were incorporated in the model as covariates. Tests of main factor effects and interaction effects were performed. Differences between individual test concentrations and between different strains were assessed by the least significance test. Heterogeneous data were analyzed using the Kruskal-Wallis test. The formation rates of the blastocysts and the proportions of the embryos with detectable Bcl2 and Fos transcripts were assessed by binary logistic regression analysis.
RESULTS
Quantitative analysis of Bcl2 and Fos expression was performed with cohorts of 30 oocytes and preimplantation embryos collected from hybrid mice. The level of expression for each was compared to that of an equivalent quantity of brain tissue. Bcl2 transcripts were detected in oocytes and zygotes but were not detected in cohorts of 2-cell-, 8-cell-, and blastocyst-stage embryos (Fig. 1A) . Fos transcripts were also detected in cohorts of hybrid oocytes and zygotes, but like Bcl2, they were not detected in 2-cell-, 8-cell-, and blastocyststage embryos (Fig. 1A) . Antibodies directed against BCL2 and FOS antigen were tested by Western blot analysis, which detected a single band of the correct size in control tissues and mouse blastocysts (Fig. 1B) . With the use of these same antibodies, immunofluorescence showed intense staining of both FOS and BCL2 antigens in all cells of the embryos, from the 2-cell to blastocyst stage, but relatively less staining in zygotes (Fig. 1C) and oocytes (not shown).
The increased staining of FOS and BCL2 antigens in the 2-cell embryo occurred in the apparent absence of their mRNA. This observation raises the question of how this increased protein occurs. To assess the role of tropic signaling in this response, zygotes were cultured individually for 20 h (to induce the relative deprivation of embryotropic signaling), and the resulting 2-cell embryos were exposed to Paf (37 nM) for 0, 20, or 40 min, and the relative changes in Bcl2 ( Fig. 2A) and Fos (Fig. 2B ) transcript levels were assayed. Paf caused a marked increase in relative concentrations of both Bcl2 and Fos transcripts compared to those of Actb at 20 min after treatment, yet by 40 min, this increase was lost. This Paf-induced increase of both transcripts required new transcription as it was blocked C) The quantitative analysis of staining of FOS showed that Paf caused a *P , 0.05 increase relative to controls, while puromycin (**P , 0.001) caused a reduction relative to both Paf-treated and control embryos. D) Monitoring staining for up to 6 h after challenge (0 h) showed that Puromycin caused a significant (P , 0.001) decline in staining relative to control medium.
by pretreatment with the RNA-polymerase inhibitor a-amanitin (Fig. 2C) . Furthermore, inhibition of PI3-kinase by LY294002 or transient increases in intracellular calcium concentrations by BAPTA-AM (Fig. 2C ) also blocked this Paf-induced pulse of Fos and Bcl2 transcription.
Calcium transients induced by Paf only lasted for ;5 min and occurred with a periodicity of around 90-120 min [12] . Between each calcium pulse, the embryo was refractory to further stimulation by Paf [12] . Given the apparently transient nature of Bcl2 and Fos expression, the pulsatile nature of Paf's action may mean these transcripts are only expressed briefly at intervals following each tropic signaling event in the early embryo. If so, it is hypothesized that their expression would display a dichotomous pattern (being present or absent), with only a proportion of embryos expressing these transcripts at any given time. To test this hypothesis, RNA was extracted from individual hybrid zygotes (control) and 2-cell embryos freshly collected from the reproductive tract. The proportion of individual 2-cell embryos that had detectable Bcl2 (Fig. 3A) or Fos (Fig. 3B) transcripts was significantly less in the embryos than in the zygotes. For those embryos that did have detectable transcripts, there were no significant differences between the relative quantities of either Bcl2 (Fig. 3C) or Fos (Fig. 3D ) transcripts in 2-cell embryos and those in zygotes. These results are consistent with the hypothesis that the persistence of maternal stores of these transcripts in zygotes is lost in the 2-cell stage and is followed by their transient periodic reexpression.
Embryos lacking the Paf receptor (Ptafr
) in the B6 background were compared with their wild-type controls (Ptafr þ/þ ). Interestingly, Bcl2 transcripts were detected in only 1 of 3 cohorts of wild-type oocytes and in 2 of 5 cohorts of Ptafr À/À oocytes. The results are presented as medians to reflect this heterogeneity (Fig. 4A) . In contrast, 1 of 3 cohorts of wildtype zygotes but 0 of 5 cohorts of Ptafr À/À zygotes contained detectable Bcl2 transcripts (Fig. 4B) . As was the case for hybrid embryos, there was an absence of transcripts from both lines at the 2-cell and blastocyst stages (Fig. 4) . For both fresh and cultured 2-cell embryos, the proportion of Ptafr þ/þ embryos with detectable Bcl2 transcripts was significantly higher than that of Ptafr À/À embryos (Fig. 4C) . Paradoxically, the relative number of transcripts was significantly higher in fresh Ptafr þ/þ embryos than in Ptafr À/À embryos and was also significantly higher in fresh Ptafr þ/þ embryos than in cultured Ptafr þ/þ embryos. There was no difference in the relative transcript number (P . 0.05) between cultured Ptafr þ/þ embryos and cultured Ptafr À/À embryos (Fig. 4D ). This may indicate some form of compensatory response under these conditions, warranting further investigation. Immunolocalization with anti-BCL2 showed antigen staining from the 2-cell stage that persisted to the blastocyst stage in both Ptafr þ/þ and Ptafr À/À embryos (Fig. 4, E and F) . The intensity of staining in Ptafr À/À embryos was subjectively less than that in Ptafr þ/þ at each stage of development, and these Ptafr þ/þ embryos of B6 background showed less intense staining than the hybrid embryos did (Fig. 1C) . The presence of this staining in Ptafr À/À embryos indicates that Paf is not the only determinant of BCL2 expression.
Treatment of 2-cell embryos with Paf caused increased immunostaining for BCL2 (Fig. 5A) and FOS (Fig. 5B) antigens. Paf treatment caused more FOS antigen staining than in embryos prior to treatment and in embryos exposed to control medium for the same duration (Fig. 5C) . Inhibition of protein synthesis by puromycin inhibited the Paf-induced increase in FOS staining (Fig. 5C) . To assess the rate of turnover of FOS protein, 2-cell embryos were exposed to Paf for 1 h and then transferred to medium containing puromycin or vehicle. Embryos were stained for FOS at 2-h intervals for 6 h. Puromycin caused an approximate 50% reduction in staining after 2-4 h and a 4-fold reduction in staining after 6 h of treatment (Fig. 5D) . FOS staining in control embryos persisted at a high level. In the 2-cell embryo, FOS antigen has a relatively short half-life, and its maintenance at high levels requires regular rounds of new synthesis. A) The proportion of zygotes that formed morphological zygotes; (B) the total number of cells within these blastocysts (mean 6 SEM); and (C) the number of cells in blastocysts that had fragmented nuclei. The results are from four independent replicates and the number of embryos is shown above each column of bars in A. There was a significant effect of HA14-1 on the proportion of blastocysts formed (P , 0.01), (B) the average number of nuclei per embryo (P , 0.001), and (C) number of cells with fragmented nuclei (P , 0.01). Paf caused a significant improvement in the proportion of blastocysts (P , 0.05), the number of cells (P , 0.001) and reduced the number of fragmented nuclei (P , 0.01). There was no interaction effect between HA14-1 and Paf on any of these 3 parameters.
Paf-INDUCED TRANSCRIPTION OF ONCOGENES
HA14-1 is a membrane-permeable antagonist of BCL2 [28] . The addition of this drug to medium caused a dosedependent decrease in the capacity of cultured B6 zygotes to develop to morphological blastocysts (Fig. 6A) , and those zygotes capable of forming blastocysts had fewer cells (Fig.  6B) , and more of their nuclei showed morphological signs of apoptosis (Fig. 6C) . The simultaneous addition of Paf to medium (37 nM) improved the development of embryos and partially reversed the loss of development caused by HA14-1. Paf caused an increase in the total cell number and decreased the number of apoptotic cells. Together these results show that the level and action of BCL2 within the preimplantation embryo influences normal embryo development in vitro and is governed, at least in part, by the actions of the autocrine embryotropin Paf.
DISCUSSION
This study shows that the FOS and BCL2 proto-oncogene antigens are present within the preimplantation embryo. Both proto-oncogenes showed marked staining from the 2-cell to blastocyst stage, but there was relatively little staining in zygotes. Transcripts for these proto-oncogenes were present in RNA pooled from groups of oocytes and zygotes but were not detected in RNA from embryos collected directly from the reproductive tract over the 2-cell to blastocyst stage. This reciprocal pattern of expression of transcripts and antigens seems paradoxical. More detailed analysis showed that only a small proportion of individual 2-cell embryos showed Fos and Bcl2 expression at a given time. Furthermore, transcription from these genes was acutely induced by Paf in 2-cell embryos, and the absence of the Paf receptor reduced the proportion of embryos with this transcription. The transcripts generated by embryotropic action had a short half-life, while their protein products persisted for several hours. This pattern of transcript expression indicates that maternal stores of these transcripts persist to the zygote stage, but by the 2-cell stage, these stores were degraded and replaced by periodic pulses of their transcription induced by embryotropins. The differences in the life spans of the resulting RNA and proteins mean that the periodic pulses of transcription were sufficient to maintain these two oncogene proteins at relatively high levels during preimplantation embryo development.
The low level of antigen staining in oocytes and zygotes indicates that there are limited maternal stores of these proteins. The accumulation of the antigens first occurred in the 2-cell embryo at the time that maternal transcript stores were degraded and the time at which periodic transient transcription from the embryonic genome was first observed. The increased antigenic expression of BCL2 and FOS occurred acutely in response to Paf treatment, and for FOS, this required puromycin-dependent protein synthesis. Paf signaling occurs with a periodicity of approximately 90-120 min [12] . The FOS antigen generated as a consequence of Paf stimulation had a half-life of 2-4 h in the 2-cell embryo. The results indicate a picture of recurrent periodic acute induction of oncogene transcription that leads to synthesis of new protein. The halflife of the protein would allow much of it to persist until the next round of transcription.
We believe this is the first description of embryotropininduced transcription in the 2-cell embryo, a time when definitive transcription from the embryonic genome first occurs. The relatively transient nature of these resulting transcripts accounts for the conflicting reports on the expression of FOS and BCL2 in the early embryo [21, 22] .
The half-life of RNA species is known to be one of the most important aspects of their regulation. RNA stability is governed by many factors, with the sequence of the 3 0 -untranslated region (UTR) being especially important. The cis-acting sequence elements (such as adenine and uracil [AU]-rich region elements) within the 3 0 -UTR region of RNA are associated with their short half-life [29] . RNA species transcribed in response to growth and tropic factors are enriched with species containing such cis-acting sequences. Both the Bcl2 [30] and Fos [31] genes possess these elements and these are important in regulating their short half-life. Fos transcripts are known to typically have a very short half-life (10-15 min) [32] . The kinetics of Bcl2 transcript degradation has been less well studied but may be longer in somatic cells, at approximately 2 h [33] [34] [35] . The apparently rapid turnover of Bcl2 transcripts in the embryo may suggest that alternative mechanisms of regulating the half-life of this transcript may exist in the embryo. While the half-life of Fos transcripts is only 10-15 min, FOS protein is reported to have a half-life of around 2 h [36] and BCL2 of around 8-20 h in somatic cells [37] . In the 2-cell embryo, we found FOS also had a half-life of 2-4 h. The differences in the life spans between transcripts and proteins provide for a mechanism by which short-lived transcription induced by periodic tropic signaling creates relatively stable levels of proto-oncogene protein expression in the embryo. Paf is a known autocrine embryotropin. It acts via a membrane receptor to induce periodic calcium transients from the late zygote stage. The resulting calcium transients persist for approximately 5 min [12] and result in the nuclear localization and serine 133 phosphorylation of CREB at the 2-cell stage [13, 15] . The induction of transcription by exogenous Paf required the presence of the Paf receptor, demonstrating the specificity of this response. It was interesting to note that while Paf receptor null embryos collected from the reproductive tract were less likely to contain Bcl2 and Fos transcripts, some embryos still did express these genes. Furthermore, Ptafr À/À embryos did stain for BCL2 expression albeit at a lower level than wild-type controls. It was also noteworthy that the level of staining in wild types was lower than in hybrid embryos collected fresh from the reproductive tract (Fig. 1C) . This may reflect the relative deprivation of tropic signaling that is known to occur in vitro [23] and the well-known sensitivity of inbred strains to the adverse effects of culture compared to hybrid embryos [26] . These results indicate that while Paf is an important signal for the induction of this transcription, it is not the only signal. This is consistent with the known overlapping actions of embryotropins via PI3-kinase in the embryo [3] . Furthermore, insulin and IGF1 caused a time-dependent increase in the Fos transcription in rabbit blastocysts, with transcription maxima occurring 10 min (insulin) or 30 min (IGF1) after challenge, that subsided to baseline levels within 40 min [4] . It has also been shown that EGF and TGFA induced the expression of Fos transcripts in bovine blastocysts [5] . It is likely that the overlapping effects of a number of embryotropins act via PI3-kinase to induce the transient transcription of key proto-oncogenes. The periodic action of multiple embryotropins across the preimplantation phase of early embryo development provides a mechanism for the relatively stable expression of the protein products of these genes (Fig. 7) .
Fos and Bcl2 transcriptions are commonly induced by the CREB family of transcription factors. Activated CREB recognizes and binds to CREB response elements (CRE). These response elements may be palindromes (TGACGTCA) or half sites (CGTCA/TGACG) within the promoters of many genes [16, 18] . Phosphorylated CREB recruits the coactivator CREB binding protein (CREBBP) and the core transcription machinery, resulting in the initiation of transcription of target loci. Systematic genome-wide analyses suggest that CREB targets approximately 4084 human loci, with the total number of CREs in the genome being 750 837 [16] . Importantly, 332 of a total of 866 human transcription factor genes are putative CREB targets [16] . The richness of CREB's potential targets means that CREB activation has the capacity to not only alter the transcriptome directly but also to create secondary effects by its capacity to recruit the expression of new transcription factors. By such mechanisms, autocrine signaling in the embryo may have the capacity to induce a significant transformative elaboration of the embryonic transcriptome.
It has been common, to date, to perform transcriptome analysis with relatively large cohorts of embryos. This study shows that the analysis of groups of embryos can disguise important information on the regulation of embryo development by favoring the detection of relatively stable mRNA species and underreporting the expression of transiently expressed transcripts. A detailed analysis and understanding of the dynamics of expression and stability of key mRNA species are central to an understanding of embryo development and survival.
The culture of zygotes under limiting conditions in vitro commonly reduces their survival and developmental potential.
The capacity of Paf to increase Bcl2 and Fos expression in a PI3-kinase-dependent manner and the demonstration that BCL2 activity supports the normal development of the embryo in vitro provide a link between autocrine tropic stimulation of the early embryo and the generation of a transcriptome and proteome that supports the growth and survival of the preimplantation embryo. It also illuminates how culture under limiting conditions can perturb the normal regulation of early transcription events within the embryo that lead to their reduced viability.
